Question 1

Does Arrowstreet Capital own CORT stock?

Accepted Answer

No. Arrowstreet Capital exited its CORT (Corcept Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 67,972 shares worth $2.7M.

Question 2

How many shares of CORT does Arrowstreet Capital own?

Accepted Answer

None since Q2 2026, when Arrowstreet Capital exited the position. Its Q1 2026 13F listed 67,972 shares worth $2.7M.

Question 3

What is Arrowstreet Capital's CORT position worth?

Accepted Answer

Arrowstreet Capital's CORT position was worth $2.7M in its Q1 2026 13F, before the exit in Q2 2026.

Question 4

Is Arrowstreet Capital buying or selling CORT?

Accepted Answer

In Q2 2026, Arrowstreet Capital exited its entire CORT position.

Question 5

When did Arrowstreet Capital first buy CORT?

Accepted Answer

Arrowstreet Capital already held CORT in its Q4 2018 13F, the earliest on record, and listed it in 26 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$86.95	0
2026-Q1	Decreased	67,972	-54.6%	$2.7M	0.0%	$40.31	0
2025-Q4	Decreased	149,845	-59.4%	$5.2M	0.0%	$34.80	0
2025-Q3	Decreased	369,388	-53.2%	$30.7M	0.0%	$83.11	0
2025-Q2	Decreased	788,809	-47.1%	$57.9M	0.0%	$73.40	0
2025-Q1	Decreased	1.5M	-9.3%	$170.4M	0.1%	$114.22	0
2024-Q4	Increased	1.6M	+4.1%	$82.9M	0.1%	$50.39	31
2024-Q3	Increased	1.6M	+6.5%	$73.2M	0.1%	$46.28	32